These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 34033103)

  • 1. Detection of Immunogenic Cell Death in Tumor Vaccination Mouse Model.
    Tatsuno K; Han P; Edelson R; Hanlon D
    Methods Mol Biol; 2021; 2255():171-186. PubMed ID: 34033103
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chromomycin A
    Florêncio KGD; Edson EA; Fernandes KSDS; Luiz JPM; Pinto FDCL; Pessoa ODL; Cunha FQ; Machado-Neto JA; Wilke DV
    Front Immunol; 2022; 13():941757. PubMed ID: 36439184
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ZnO-based multifunctional nanocomposites to inhibit progression and metastasis of melanoma by eliciting antitumor immunity via immunogenic cell death.
    Zhang Y; Guo C; Liu L; Xu J; Jiang H; Li D; Lan J; Li J; Yang J; Tu Q; Sun X; Alamgir M; Chen X; Shen G; Zhu J; Tao J
    Theranostics; 2020; 10(24):11197-11214. PubMed ID: 33042278
    [No Abstract]   [Full Text] [Related]  

  • 4. Damage-associated molecular patterns (DAMPs) related to immunogenic cell death are differentially triggered by clinically relevant chemotherapeutics in lung adenocarcinoma cells.
    Solari JIG; Filippi-Chiela E; Pilar ES; Nunes V; Gonzalez EA; Figueiró F; Andrade CF; Klamt F
    BMC Cancer; 2020 May; 20(1):474. PubMed ID: 32456685
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Imiquimod Exerts Antitumor Effects by Inducing Immunogenic Cell Death and Is Enhanced by the Glycolytic Inhibitor 2-Deoxyglucose.
    Huang SW; Wang ST; Chang SH; Chuang KC; Wang HY; Kao JK; Liang SM; Wu CY; Kao SH; Chen YJ; Shieh JJ
    J Invest Dermatol; 2020 Sep; 140(9):1771-1783.e6. PubMed ID: 32035924
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel calreticulin-nanoparticle in combination with focused ultrasound induces immunogenic cell death in melanoma to enhance antitumor immunity.
    Sethuraman SN; Singh MP; Patil G; Li S; Fiering S; Hoopes PJ; Guha C; Malayer J; Ranjan A
    Theranostics; 2020; 10(8):3397-3412. PubMed ID: 32206098
    [No Abstract]   [Full Text] [Related]  

  • 7. Local secretion of IL-12 augments the therapeutic impact of dendritic cell-tumor cell fusion vaccination.
    Tan C; Dannull J; Nair SK; Ding E; Tyler DS; Pruitt SK; Lee WT
    J Surg Res; 2013 Dec; 185(2):904-11. PubMed ID: 23891424
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vaccination using melanoma cells treated with p19arf and interferon beta gene transfer in a mouse model: a novel combination for cancer immunotherapy.
    Medrano RF; Catani JP; Ribeiro AH; Tomaz SL; Merkel CA; Costanzi-Strauss E; Strauss BE
    Cancer Immunol Immunother; 2016 Apr; 65(4):371-82. PubMed ID: 26887933
    [TBL] [Abstract][Full Text] [Related]  

  • 9.
    Araki K; Yamamuro N; Tomonobu N; Kumon H
    Anticancer Res; 2021 Oct; 41(10):4837-4855. PubMed ID: 34593432
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting immunogenic cell death in cancer.
    Ahmed A; Tait SWG
    Mol Oncol; 2020 Dec; 14(12):2994-3006. PubMed ID: 33179413
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Consensus guidelines for the detection of immunogenic cell death.
    Kepp O; Senovilla L; Vitale I; Vacchelli E; Adjemian S; Agostinis P; Apetoh L; Aranda F; Barnaba V; Bloy N; Bracci L; Breckpot K; Brough D; Buqué A; Castro MG; Cirone M; Colombo MI; Cremer I; Demaria S; Dini L; Eliopoulos AG; Faggioni A; Formenti SC; Fučíková J; Gabriele L; Gaipl US; Galon J; Garg A; Ghiringhelli F; Giese NA; Guo ZS; Hemminki A; Herrmann M; Hodge JW; Holdenrieder S; Honeychurch J; Hu HM; Huang X; Illidge TM; Kono K; Korbelik M; Krysko DV; Loi S; Lowenstein PR; Lugli E; Ma Y; Madeo F; Manfredi AA; Martins I; Mavilio D; Menger L; Merendino N; Michaud M; Mignot G; Mossman KL; Multhoff G; Oehler R; Palombo F; Panaretakis T; Pol J; Proietti E; Ricci JE; Riganti C; Rovere-Querini P; Rubartelli A; Sistigu A; Smyth MJ; Sonnemann J; Spisek R; Stagg J; Sukkurwala AQ; Tartour E; Thorburn A; Thorne SH; Vandenabeele P; Velotti F; Workenhe ST; Yang H; Zong WX; Zitvogel L; Kroemer G; Galluzzi L
    Oncoimmunology; 2014 Oct; 3(9):e955691. PubMed ID: 25941621
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Natural Compounds of Marine Origin as Inducers of Immunogenic Cell Death (ICD): Potential Role for Cancer Interception and Therapy.
    Sansone C; Bruno A; Piscitelli C; Baci D; Fontana A; Brunet C; Noonan DM; Albini A
    Cells; 2021 Jan; 10(2):. PubMed ID: 33504012
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An ER-Targeting Iridium(III) Complex That Induces Immunogenic Cell Death in Non-Small-Cell Lung Cancer.
    Wang L; Guan R; Xie L; Liao X; Xiong K; Rees TW; Chen Y; Ji L; Chao H
    Angew Chem Int Ed Engl; 2021 Feb; 60(9):4657-4665. PubMed ID: 33217194
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunogenic Cell Death Amplified by Co-localized Adjuvant Delivery for Cancer Immunotherapy.
    Fan Y; Kuai R; Xu Y; Ochyl LJ; Irvine DJ; Moon JJ
    Nano Lett; 2017 Dec; 17(12):7387-7393. PubMed ID: 29144754
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nanomicelle protects the immune activation effects of Paclitaxel and sensitizes tumors to anti-PD-1 Immunotherapy.
    Yang Q; Shi G; Chen X; Lin Y; Cheng L; Jiang Q; Yan X; Jiang M; Li Y; Zhang H; Wang H; Wang Y; Wang Q; Zhang Y; Liu Y; Su X; Dai L; Tang M; Li J; Zhang L; Qian Z; Yu D; Deng H
    Theranostics; 2020; 10(18):8382-8399. PubMed ID: 32724476
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Calreticulin-Multifunctional Chaperone in Immunogenic Cell Death: Potential Significance as a Prognostic Biomarker in Ovarian Cancer Patients.
    Kielbik M; Szulc-Kielbik I; Klink M
    Cells; 2021 Jan; 10(1):. PubMed ID: 33440842
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Shikonin-enhanced cell immunogenicity of tumor vaccine is mediated by the differential effects of DAMP components.
    Lin TJ; Lin HT; Chang WT; Mitapalli S P; Hsiao PW; Yin SY; Yang NS
    Mol Cancer; 2015 Sep; 14():174. PubMed ID: 26403780
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effective cancer immunotherapy by natural mouse conventional type-1 dendritic cells bearing dead tumor antigen.
    Wculek SK; Amores-Iniesta J; Conde-Garrosa R; Khouili SC; Melero I; Sancho D
    J Immunother Cancer; 2019 Apr; 7(1):100. PubMed ID: 30961656
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immune stimulatory antigen loaded particles combined with depletion of regulatory T-cells induce potent tumor specific immunity in a mouse model of melanoma.
    Goforth R; Salem AK; Zhu X; Miles S; Zhang XQ; Lee JH; Sandler AD
    Cancer Immunol Immunother; 2009 Apr; 58(4):517-30. PubMed ID: 18719913
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nitric Oxide Induces Immunogenic Cell Death and Potentiates Cancer Immunotherapy.
    Jiang W; Dong W; Li M; Guo Z; Wang Q; Liu Y; Bi Y; Zhou H; Wang Y
    ACS Nano; 2022 Mar; 16(3):3881-3894. PubMed ID: 35238549
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.